Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.172.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.09% | -94.81% | 46.68% | 47.51% | -156.30% |
| Total Depreciation and Amortization | -16.73% | -16.34% | -14.30% | -11.39% | 0.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.39% | -39.15% | -35.51% | -34.10% | -0.05% |
| Change in Net Operating Assets | -83.11% | 62.27% | 84.43% | -379.45% | 1,287.50% |
| Cash from Operations | -5,613.73% | 27.83% | 80.91% | -532.32% | 54.85% |
| Capital Expenditure | -- | -126.25% | 100.00% | 42.92% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -126.25% | 100.00% | 42.92% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,622.39% | 76.77% | -88.60% | -91.09% | -90.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,622.39% | 76.77% | -712.82% | 594.47% | 100.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,867.33% | 30.43% | 27.03% | -456.39% | 99.26% |